Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke
Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)
Optimal Anti-platelet Treatment for Patients With Clopidogrel Low Response
Pharmacodynamic Study on Efficacy of Clopidogrel With St. John's Wort
Proton Pump Inhibitor Versus Histamine-2 Receptor Antagonist for the Prevention of Recurrent Peptic Ulcers
Efficacy of H2 Receptor Antagonist in Prevention of Thienopyridine-related Peptic Ulcer
† Study has passed its completion date and status has not been verified in more than two years.